Huakang Pharma to increase investment in xylose production

Summary: Huakang Pharma announced that it plans to terminate its 30,000 t/a xylitol technology upgrading project. The IPO proceeds originally intended to be used in the xylitol project will be invested in its 30,000 t/a D-xylose intelligent upgrading...

Sweeteners China News 202205

www.cnchemicals.com